一个基于模型的目标产品简介用于人口修饰基因驱动器,用于疟疾控制
Agastya Mondal1, Héctor M Sánchez C1, John M Marshall1,2
1Divisions of Biostatistics & Epidemiology, School of Public Health, University of California, Berkeley, California, United States of America.
PLOS global public health
|August 6, 2025
概括
基因驱动蚊子在疟疾控制方面表现有前途. 建模表明,健身成本和效应基因有效性是实现疟疾发病率在一年内减少50%的关键,持续超过三年.
科学领域:
- 遗传学和基因组学 遗传学和基因组学
- 流行病学 流行病学
- 矢量控制是指向量控制的方法.
背景情况:
- 撒哈拉以南非洲地区疟疾传播的减少已经停滞不前.
- 基因驱动改造的蚊子为疾病控制提供了一种新的方法.
- 目标产品配置文件指导基因驱动技术的发展.
研究的目的:
- 为了研究基因驱动对人口修饰基因驱动的参数值.
- 评估基因驱动是否可以在至少三年内将临床疟疾发病率降低50%.
- 为了确定基因驱动是否可以在不到一年的时间内实现临床疟疾发病率50%的减少.
主要方法:
- 使用了一个生态流行病学模型.
- 模拟了两个具有不同传播强度的非洲环境 (布基纳法索和肯尼亚).
- 探索的关键参数包括回归率,抗性等位基因生成,健身成本和效应基因疗效.
主要成果:
- 满足"保护窗口"标准 (≥3年) 也满足了"时间到冲击"标准 (<1年).
- 基因驱动等位基因的适应性成本和效应基因的有效性是最有影响力的参数.
- 较低的功能性耐药性等位基生成率是首选的,而昂贵的非功能性耐药性等位基则有助于驱动持久性.
结论:
- 基因驱动蚊子的有效性主要是由健身成本和效应基因性能驱动的.
- 在Anopheles基因驱动器中现有的指向率是足够的.
- 产品准备的一个挑战是,关键的疗效参数只能在现场试验中可靠地测量.
相关概念视频
Mouse Models of Cancer Study
4.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
4.7K
G Protein-coupled Receptors
14.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
14.1K
Prescription, Nonprescription and Orphan Drugs
1.5K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.5K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
81
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97


